PATENT CLAIM ANALYSIS

Application Number: 15907057
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "180000"]

Abstract:
Disclosed are aqueous pharmaceutical compositions which provide sustained released delivery of corticosteroid compounds. The pharmaceutical composition comprises a soluble corticosteroid and at least one viscosity enhancing agent. Also provided are methods for using the pharmaceutical compositions in an epidural injection, intra-articular injection, or an intra-lesional injection.

Claim (Index 2):
The method of  claim 1 , wherein the soluble corticosteroid is dexamethasone sodium phosphate.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 88.0
- Lexical Diversity: 1.275
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15545204', '14162625', '15043750', '15818089', '11828561']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.764779376747966
- 35 USC 102 Novelty (BERT): 0.6615951115602237
- Combined Prediction Score: 0.7544609502291918
- Mean Citation Score: 362.791794
- Max Citation Score: 654.7074
- Similarity Product: 613.9950516142487

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test